Header?Introduce Your Patients to ASTELIN

Important Safety Information

ASTELIN is indicated for the treatment of the symptoms of seasonal allergic rhinitis (patients 5 years of age and older) and nonallergic vasomotor rhinitis (patients 12 years of age and older).

The most commonly reported adverse events in seasonal allergic rhinitis and nonallergic vasomotor rhinitis patients 12 years of age and older were bitter taste, headache, somnolence, nasal burning, and rhinitis. The adverse event profile in seasonal allergic rhinitis patients 5 to 11 years of age was similar to that in the adult population.

Prescribing Information | Privacy Policy | Sitemap

ASTELIN is distributed by Meda Pharmaceuticals Inc.